Similar Items: Druggable genome‐wide Mendelian randomization analysis identifies potential treatment targets in vascular dementia
- Advances in pharmacotherapy for vascular cognitive impairment and vascular dementia: An update of 2025
- Vascular cognitive impairment and dementia drug‐development pipeline 2025
- Visual Impairment and Handgrip Strength in Aging: Evidence from Bidirectional Mendelian Randomization
- Testing Van Gool’s Hypothesis: A Method to Predict Side Effects of Cholinesterase Inhibitors in Patients with Cellular Degenerative and Vascular Dementia
- Economic evaluations of strategies targeting pre‐diagnosis dementia populations: A systematic review
- Characterizing Digital Mindfulness Intervention Utilization and Weekly Assessments in Caregivers of Persons Living With Dementia: Secondary Analysis of a Randomized Controlled Trial